Delivery Order SPE2DB20D2014-SPE2DB25FA81V
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,805.87 firm fixed price delivery order contract has a completion date of May 2, 2024 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The $11,666.36 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major federal agency customer for Amerisourcebergen. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December...
This federal contract award is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $1,652.35. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 8, 2024 and is structured as a firm fixed-price delivery order. The contract is not designated as a set-aside....
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,055.64, is a delivery order with a firm fixed price pricing type. It has an ultimate completion date of July 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $36,972.91. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 23, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a...
This federal contract award is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $6,880.76 and an ultimate completion date of August 15, 2024. The contract is a delivery order with a firm fixed price pricing type. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
The federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,834.82 firm fixed-price delivery order contract has a completion date of November 29, 2023 and is not designated as a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The firm-fixed-price delivery order has a ceiling value of $5,141.78 and a period of performance through February 4, 2025. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded by the Defense Logistics Agency (DLA) to prime contractor AmerisourceBergen Drug Corp. The $15,312.61 firm fixed price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $3,441.69 and a completion date of December 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...